Correlation Between RAPT Therapeutics and Passage Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RAPT Therapeutics and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAPT Therapeutics and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAPT Therapeutics and Passage Bio, you can compare the effects of market volatilities on RAPT Therapeutics and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAPT Therapeutics with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAPT Therapeutics and Passage Bio.

Diversification Opportunities for RAPT Therapeutics and Passage Bio

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between RAPT and Passage is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and RAPT Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAPT Therapeutics are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of RAPT Therapeutics i.e., RAPT Therapeutics and Passage Bio go up and down completely randomly.

Pair Corralation between RAPT Therapeutics and Passage Bio

Given the investment horizon of 90 days RAPT Therapeutics is expected to generate 0.85 times more return on investment than Passage Bio. However, RAPT Therapeutics is 1.17 times less risky than Passage Bio. It trades about 0.0 of its potential returns per unit of risk. Passage Bio is currently generating about -0.17 per unit of risk. If you would invest  116.00  in RAPT Therapeutics on November 28, 2024 and sell it today you would lose (1.00) from holding RAPT Therapeutics or give up 0.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

RAPT Therapeutics  vs.  Passage Bio

 Performance 
       Timeline  
RAPT Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in RAPT Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, RAPT Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Passage Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

RAPT Therapeutics and Passage Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RAPT Therapeutics and Passage Bio

The main advantage of trading using opposite RAPT Therapeutics and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAPT Therapeutics position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.
The idea behind RAPT Therapeutics and Passage Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data